
UBX
NGSUnity Biotechnology Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Wednesday 9th July 2025
0.20
-0.10 (-33.41%)
Prev Close:0.3005
Open:0.2824
Bid:0.1764
Ask:0.1799
52 Week Range
0.203.10
Volume:630,069
Mkt Cap:6 M
30
MarketXLS Rank ®
Weak Hold
Price Target
$0.23
+14.9%
Financial Statements
UBX - Balance Sheet (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Invalid date | |
---|---|---|---|---|---|---|---|---|
Accounts Payable | 997000.0 | 1 M | 2 M | 2 M | 3 M | 5 M | 5 M | |
Accrued Interest Receivable | 139000.0 | 84000.0 | 235000.0 | |||||
Accumulated Depreciation & Depletion | -9 M | -9 M | -13 M | -12 M | -10 M | -6 M | -4 M | |
Cash And Equivalents | 8 M | 20 M | 13 M | 33 M | 18 M | 37 M | 15 M | |
Cash Cash Equivalents And Short Term Investments | 23 M | 43 M | 95 M | 88 M | 98 M | 127 M | 171 M | |
Cash Equivalents | 1 M | 550000.0 | ||||||
Common Stock | 2000.0 | 2000.0 | 1000.0 | 1000.0 | -205000.0 | -623000.0 | -597000.0 | |
Current Accrued Expenses | 8 M | 6 M | 8 M | 10 M | 12 M | 5 M | 5 M | |
Current Capital Lease Obligation | -4 M | -3 M | -3 M | -4 M | -5 M | 5 M | 2 M | |
Current Deferred Revenue | 216000.0 | |||||||
Current Deferred Taxes Liabilities | -3 M | -4 M | -6 M | -6 M | -7 M | |||
Employee Benefits | 6 M | 4 M | ||||||
Float Term Debt | 20 M | 24 M | 38 M | 49 M | 59 M | |||
Interest Payable | -2 M | -4 M | 3 M | 1 M | ||||
Long Term Capital Lease Obligation | 20 M | 24 M | 27 M | 30 M | 34 M | |||
Long Term Debt And Capital Lease Obligation | 20 M | 24 M | 38 M | 49 M | 59 M | |||
Long Term Provisions | 2 M | |||||||
Net Other Unrealized Gain Loss | 99000.0 | |||||||
Non Current Deferred Liabilities | 13 M | 2 M | ||||||
Non Current Deferred Taxes Assets | 121 M | 114 M | 106 M | 93 M | 78 M | 50 M | 38 M | |
Other Current Liabilities | 1 M | |||||||
Other Payable | -29 M | -99 M | 5 M | 5 M | ||||
Payables | 997000.0 | 1 M | 2 M | 2 M | 3 M | 5 M | 5 M | |
Retained Earnings | -510 M | -484 M | -445 M | -400 M | -339 M | -245 M | -163 M | |
Total Capitalization | 26 M | 52 M | 105 M | 126 M | 166 M | 121 M | 161 M | |
Total Equity Gross Minority | 7 M | 28 M | 56 M | 60 M | 83 M | 121 M | 161 M | |
Total Equity Gross Minority Interest | 7 M | 28 M | 56 M | 60 M | 83 M | 121 M | 161 M | |
Total Liabilities And Total Equity Gross Minority Interest | 38 M | 66 M | 124 M | 125 M | 156 M | 151 M | 181 M | |
Total Non Current Liabilities Net Minority Interes | 22 M | 29 M | 49 M | 49 M | 59 M | 19 M | 11 M | |
Unearned Premiums | -1 M | -3 M | -2 M | |||||
Working Capital | 15 M | 39 M | 77 M | 74 M | 86 M | 118 M | 163 M | |
Addpaid | 517 M | 513 M | 501 M | 460 M | 422 M | 367 M | 325 M | |
Capstk | 2000.0 | 2000.0 | 1000.0 | 1000.0 | -205000.0 | -623000.0 | -597000.0 | |
Comstkeqty | 6 M | 28 M | 56 M | 60 M | 83 M | 121 M | 161 M | |
Constr | 7000.0 | |||||||
Curdebt | 9 M | 3 M | ||||||
Curdebtcaplease | 9 M | 3 M | ||||||
Curdefliab | 216000.0 | |||||||
Gainlossnoearn | 90000.0 | -95000.0 | ||||||
Grosppe | 22 M | 27 M | 40 M | 43 M | 46 M | 23 M | 10 M | |
Invadv | 2 M | 18 M | 3 M | |||||
Netppe | 12 M | 18 M | 27 M | 31 M | 36 M | 17 M | 6 M | |
Noncurdefliab | -671000.0 | -1 M | -1 M | -1 M | -2 M | |||
Othca | 17 M | 17 M | 18 M | 13 M | 7 M | 10 M | 4 M | |
Othnca | 1 M | 1 M | 948000.0 | 987000.0 | 1 M | 2 M | 2 M | |
Othncl | 2 M | 6 M | 11 M | 23000.0 | 1 M | 3 M | ||
Othprop | 12 M | 18 M | 27 M | 31 M | 36 M | 17 M | 6 M | |
Othrec | 236000.0 | |||||||
Payacc | 9 M | 8 M | 10 M | 12 M | 14 M | 10 M | 10 M | |
Prepaid | 1 M | 3 M | 2 M | 2 M | 3 M | 2 M | 2 M | |
Restcash | 8 M | 21 M | 14 M | 550000.0 | 19 M | |||
Totassets | 38 M | 66 M | 124 M | 125 M | 156 M | 151 M | 181 M | |
Totca | 24 M | 47 M | 97 M | 91 M | 101 M | 129 M | 173 M | |
Totcl | 9 M | 8 M | 20 M | 17 M | 14 M | 11 M | 10 M | |
Toteqty | 6 M | 28 M | 56 M | 60 M | 83 M | 121 M | 161 M | |
Totliab | 31 M | 37 M | 68 M | 65 M | 73 M | 31 M | 21 M | |
Totnca | 13 M | 19 M | 28 M | 34 M | 55 M | 22 M | 8 M | |
Totncl | 22 M | 29 M | 49 M | 49 M | 59 M | 19 M | 11 M |